 Treatment acute myelocytic leukemia allogeneic bone marrow transplantation preparation twenty-seven patients acute myelocytic leukemia AML mg/kg days cyclophosphamide mg/kg days allogeneic bone marrow transplantation HLA-identical antigen disparate sibling patients first complete remission second complete remission initial relapse patients primary refractory disease second subsequent relapse preceding hematologic disorder leukemia-free survival LFS actuarial probability relapse group multivariate analyses relapse LFS advanced disease phase French-American-British classification LFS first remission patients short time interval diagnosis transplantation study attractive preparative regimen marrow transplantation patients AML prognostic factors relapse LFS similar regimens total body irradiation